Skip to content
Home
About us
Co-founders
Our Team
Our Product Pipeline
Our Technology
Scientific Advisors
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
AAV – mediated gene therapy
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Home
About us
Co-founders
Our Team
Our Product Pipeline
Our Technology
Scientific Advisors
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
AAV – mediated gene therapy
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Endiya Partners invest in Cell Therapy Company Eyestem
Home
update
Endiya Partners invest in Cell Therapy Company Eyestem
Post Author:
eyetem@admin
Post navigation
Previous Post
Eyestem announces second round of funding for Eyecyte-RPE
TM
from Kotak Private Equity and original investors
Next Post
Eyestem announces award of its US patent for creation of Retinal Pigment Epithelium, Photoreceptors and Retinal Organoids
